Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in Birmingham, AL
NPI: 1275740060Primary Employer
Birmingham VAMC
va.gov
HQ Phone
Mobile
Get Victor's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 42 | 47 |
Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States.
Authors: Daniel Claassen
Publication Date: 2018-02-01
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
Authors: Rajeev Kumar, Mark Gudesblatt, Erin Furr Stimming, Christina Vaughan, Daniel Claassen, Joseph Jankovic, Samuel Frank, Lawrence Elmer, William Mallonee, Sandra Kostyk, Andrew Duker, Amy Colcher
Journal: JAMA Neurol
Lead Sponsor: Michael J. Fox Foundation for Parkinson's Research
Collaborators: Institute for Neurodegenerative Disorders
Lead Sponsor: UniQure Biopharma B.V.
Intervention / Treatment: GENETIC: intra-striatal rAAV5-miHTT, OTHER: Imitation (sham) surgery
Lead Sponsor: University of Alabama at Birmingham
Intervention / Treatment: DEVICE: Unframed Virtual Cone